{
  "id": 4312614,
  "title": "Twice-daily radiation linked to better quality of life in lung cancer trial",
  "url": "https://urgent.news/2026/08/30/twice-daily-radiation-linked-to-better-quality-of-life-in-lung-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-30T00:30:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-daily-linked-quality-life-lung.html"
  },
  "original_language": "en",
  "account": "A follow-up study to a previous one found that twice-daily radiation may improve quality of life for lung cancer patients, even though adding immunotherapy did not increase overall survival. The NRG-LU005 trial evaluated atezolizumab (Tecentriq) alongside standard-of-care concurrent chemoradiation for limited-stage small-cell lung cancer. Although the study showed no benefit in overall survival with atezolizumab, a subset analysis revealed that patients receiving twice-daily radiation experienced less long-term decline in quality of life compared to those who received once-daily radiation. However, the radiation schedule was not randomized, and the results may be influenced by selection bias, as healthier patients were more likely to complete the patient-reported outcome surveys.",
  "summary": "Previously, the primary endpoint results of the NRG-LU005 (NCT03811002) study assessing the addition of the immunotherapy drug atezolizumab (Tecentriq) to standard-of-care concurrent chemoradiation for limited-stage small-cell lung cancer were reported at the American Society for Radiation Oncology 2024 Annual Meeting. Those results showed that adding atezolizumab did not improve overall survival…",
  "key_points": [
    "Twice-daily radiation improves lung cancer patients' quality of life",
    "Atezolizumab (Tecentriq) did not increase overall survival",
    "Study's radiation schedule may be biased by healthier patient selection"
  ],
  "editors_take": "Twice-daily radiation in lung cancer treatment appears to preserve quality of life better than once-daily radiation, a finding that may influence treatment decisions despite study limitations.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}